What question did this study set out to answer?

This research aims to identify molecular drivers of prostate cancer disparities linked to ancestry, focusing on biological differences between Black and White patients.

January 22, 2026Cancer Research

Abstract A057: Integrated proteogenomics uncovers ancestry-specific and shared molecular drivers in localized prostate cancer

Q: What does this research mean for the field?

Ancestry-specific biomarker panels improve risk prediction for prostate cancer with AUC exceeding 0.8, outperforming traditional PSA and pathology models. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

View Full Paper

Ask AI

Bookmark

Key result

Ancestry-specific biomarker panels outperform traditional PSA and pathology models for prostate cancer risk prediction.

Why the study?

Black men experience higher incidence and mortality rates from prostate cancer, but the molecular drivers of outcome disparities are not clearly defined.

Does multi-omics analysis identify ancestry-specific molecular drivers and prognostic markers in localized prostate cancer?

Population

112 localized PCa patients (57 Black, 55 White) in the Military Health System

Comparison

Black patients vs White patients

Design

Multi-omics observational cohort study

Authors

CSCara C. SchaferHenry M. Jackson Foundation TATamara AbulezGynecologic Oncology Group XZXijun ZhangPrecision for Medicine (United States)

Discussion

Member takes

Implication

Ancestry-specific panels may refine prostate cancer prognostication across ancestries; hypothesis-generating and warrants prospective validation.

Key Points

This research aims to identify molecular drivers of prostate cancer disparities linked to ancestry, focusing on biological differences between Black and White patients.
Conducted multi-omics analysis on tumors from 112 patients, including whole genome sequencing and proteomic approaches.
Used over-representation analyses and Multi-Omics Gene-Set Analysis to identify ancestry-associated features.
Applied integrative clustering with iClusterBayes to define molecular subtypes across multi-omics data.
Prognostic significance was assessed through Cox proportional hazards modeling and Kaplan-Meier analyses.
Black patients exhibited greater genomic variability and pronounced androgen response compared to White patients.
White patients showed higher frequencies of DNA repair gene deletions and enriched mTORC1 activity.
Identified ancestry-specific kinase dependencies, revealing distinct signaling pathways for each group.
Developed integrated biomarker panels that outperformed traditional PSA models in risk prediction.

Structured PICO

Does multi-omics analysis identify ancestry-specific molecular drivers and prognostic markers in localized prostate cancer?

Population

112 patients with localized prostate cancer (57 Black, 55 White) from the Military Health System

Intervention

Multi-omics analysis (whole genome sequencing, quantitative proteomics, and phosphoproteomics)

Comparator

Comparison between Black and White patients

Outcome

Ancestry-associated biological differences and prognostic markerssurrogate

Integrated proteogenomics identifies ancestry-specific molecular subtypes and prognostic biomarkers in localized prostate cancer that outperform standard PSA and pathology models.

Cite This Study

Schafer et al. (2026) studied this question. Ancestry-specific biomarker panels improved risk prediction for prostate cancer with AUC exceeding 0.8, outperforming traditional PSA and pathology models.

synapsesocial.com/papers/6971bdcf642b1836717e27f1 https://doi.org/10.1158/1538-7445.prostateca26-a057

View Full Paper

Ask AI

Bookmark

Implication

Ancestry-specific panels may refine prostate cancer prognostication across ancestries; hypothesis-generating and warrants prospective validation.

Abstract A057: Integrated proteogenomics uncovers ancestry-specific and shared molecular drivers in localized prostate cancer

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Abstract A057: Integrated proteogenomics uncovers ancestry-specific and shared molecular drivers in localized prostate cancer

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider